Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Drug Alcohol Depend. 2018 Jul 24;191:56–62. doi: 10.1016/j.drugalcdep.2018.06.021

Table 1.

Prevalence of predisposing, enabling and need factors of primary care patients with alcohol use disorders and stratified by receipt of any evidence-based treatment and treatment type.

All
Received any evidence-based practice
No evidence-based practice
P-value Received brief therapy
No brief therapy
P-value Received XR-NTX
No XR-NTX
P-value
Factor N/Mean %/SD N/Mean %/SD N/Mean %/SD N/Mean %/SD N/Mean %/SD N/Mean %/SD N/Mean %/SD
Predisposing
Age 43.0 11.8 45.0 11.3 42.0 12.0 0.046 44.8 11.21 42.3 12.02 0.105 48.0 11.59 42.2 11.71 0.005
Male 219 75.5 62 66.7 157 79.7 0.016 54 65.9 165 79.3 0.016 22 59.5 197 77.9 0.015
White 118 40.7 45 48.4 73 37.1 0.067 40 48.8 78 37.5 0.078 23 62.2 95 37.5 0.004
Hispanic 98 33.8 31 33.3 67 34.0 0.909 28 34.1 70 33.7 0.936 10 27.0 88 34.8 0.352
Married/living w partner 55 19.0 22 23.7 33 16.8 0.162 18 22.0 37 17.8 0.415 10 27.0 45 17.8 0.181
High school education or more 123 42.4 48 51.6 75 38.1 0.029 42 51.2 81 38.9 0.057 23 62.2 100 39.5 0.009
Enabling/inhibiting resources
Income over $20,000 per year 70 24.3 30 32.6 40 20.4 0.024 25 30.9 45 21.7 0.105 13 35.1 57 22.7 0.100
Homeless 136 46.9 25 26.9 111 56.3 <0.001 24 29.3 112 53.8 <0.001 10 27.0 126 49.8 0.010
Working full or part-time 83 28.6 32 34.4 51 25.9 0.134 27 32.9 56 26.9 0.308 14 37.8 69 27.3 0.184
Ever talked to professional about alcohol use 151 52.2 61 65.6 90 45.9 0.002 54 65.9 97 46.9 0.004 25 67.6 126 50.0 0.046
Received treatment for alcohol in past 12 months 32 11.1 15 16.1 17 8.7 0.059 12 14.6 20 9.7 0.225 6 16.2 26 10.3 0.286
PHQ8 scale for depression 10.9 6.5 12.1 6.9 10.3 6.2 0.028 12.2 6.83 10.4 6.26 0.032 11.4 7.31 10.8 6.34 0.623
Need
Co-occurring diagnosis of opioid use disorder in remission 72 24.8 25 26.9 47 23.9 0.578 22 26.8 50 24.0 0.620 12 32.4 60 23.7 0.252
ER visit or overnight hospital stay in past 90 days 103 35.5 33 35.5 70 35.5 0.993 29 35.4 74 35.6 0.973 13 35.1 90 35.6 0.959
Negative consequences from substance use 8.5 5.0 10.0 4.6 7.7 5.0 <0.001 9.7 4.79 8.0 5.04 0.006 10.6 4.17 8.2 5.08 0.006
Received XR-NTX 37 12.8 - - - - - 26 31.7 11 5.3 <0.001 - - - - -
Received brief therapy 82 28.3 - - - - - - - - - - 26 70.3 56 22.1 <0.001

Note: XR-NTX = Injectable Extended-Release Naltrexone; SD = standard deviation; PHQ8 = eight-item Patient Health Questionnaire depression scale; ER = emergency room.